Resources Repository
-
Online LearningVideo, Teaching Resource 2010TED Talk. The Art of Choosing
In this talk, Sheena Iyengar challenges three key assumptions of the standard economic model of …
In this talk, Sheena Iyengar challenges three key assumptions of the standard economic model of choice: 1) that it is always in the individual’s best interests to choose for themselves, 2) that more choice are always better, and 3) that we should never say no to choice. In particular, she highlights differences in the way people view choice in the US and in other parts of the world. Iyengar argues that if we were to…
Decision Psychology | Child/Nutrition | Preferences/Values | Education/Labor | High School | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Decision Making/Leadership -
Online LearningVideo, Teaching Resource 2010TED Talk. The Riddle of Experience vs. Memory
In recent years, much attention has been devoted to the study of happiness, yet Daniel …
In recent years, much attention has been devoted to the study of happiness, yet Daniel Kahneman argues that there is confusion around defining happiness or well-being. He distinguishes between the happiness of our “experiencing selves” (whether we are happy in the moment) and our “remembering selves” (whether we are happy with the state of our lives on reflection). When we make choices, therefore, our decisions may be biased toward pleasing either the experiencing or remembering…
Decision Psychology | Chronic Disease/Risk | Preferences/Values | Culture/Society | Health/Medicine | High School | College | Graduate | Doctoral | Professional | Critical Thinking/Analysis | Decision Making/Leadership -
ArticlePublication 2009Cost-Effectiveness of HPV Vaccination and Cervical Cancer Screening in Women Aged 30+ Years in the U.S.
The objective of the study was to assess the health and economic outcomes of HPV …
The objective of the study was to assess the health and economic outcomes of HPV vaccination in older U.S. women. The authors conducted a cost-effectiveness analysis with an empirically calibrated model using data from published literature; interventions included HPV vaccination added to screening strategies that differ by test (cytology or HPV DNA testing), frequency, and start age versus screening alone.They found that in the context of annual or biennial screening, HPV vaccination of women aged…
Chronic Disease/Risk | Microsimulation | Cost-Effectiveness Analysis | Infectious Diseases | Clinical Care | Economics/Finance | Health/Medicine | Science/Technology | North America -
ReviewPublication 2006Public Health Policy for Cervical Cancer Prevention: Decision Science, Economic Evaluation, & Mathematical Modeling
Several factors are changing the landscape of cervical cancer control, including a better understanding of …
Several factors are changing the landscape of cervical cancer control, including a better understanding of the natural history of human papillomavirus (HPV), reliable assays for detecting high-risk HPV infections, and a soon to be available HPV-16/18 vaccine. There are important differences in the relevant policy questions for different settings. By synthesizing and integrating the best available data, the use of modeling in a decision analytic framework can identify those factors most likely to influence outcomes,…
Chronic Disease/Risk | Mathematical Models | Decision Analysis | Cost-Effectiveness Analysis | Infectious Diseases | Economics/Finance | Health/Medicine | Science/Technology | Global -
ReviewPublication 2003Public Health Policy and Cost-Effectiveness Analysis
This chapter presents an overview of the uses for cost-effectiveness analysis and disease-simulation modeling to …
This chapter presents an overview of the uses for cost-effectiveness analysis and disease-simulation modeling to rigorously evaluate alternatives to reduce mortality from cervical cancer. Scientific advances have provided opportunities over time to revisit strategies for cervical cancer prevention. How to invest health resources wisely, such that public health benefits are maximized-and opportunity costs are minimized-is a critical question in the setting of enhanced cytologic screening methods, human papillomavirus DNA testing, and vaccine development. Developing sound…
Chronic Disease/Risk | Mathematical Models | Cost-Effectiveness Analysis | Infectious Diseases | Health Systems | Policy/Regulation | Health/Medicine | Global